sumatriptan
Diclofenac-potassium seemed to be as        well tolerated as placebo, with fewer adverse events reported than after       sumatriptan treatment and with more patients assessing the overall tolerability       of diclofenac-potassium better than that of sumatriptan.
Diclofenac-potassium seemed to be as        well tolerated as placebo, with fewer adverse events reported than after        @OBJECT$  @SUBJECT$  @PREDICAT$  and with more patients assessing the overall tolerability       of diclofenac-potassium better than that of sumatriptan.